您的位置: 首页 > 农业专利 > 详情页

COMPOSITIONS ET MÉTHODES UTILISÉES POUR L'INGÉNIERIE TISSULAIRE ET DES THÉRAPIES FONDÉES SUR DES CELLULES
专利权人:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION
发明人:
BOTCHWEY, III, EDWARD A.,LAUGHLIN, MARY J.,LYNCH, KEVIN R.,DAS, ANUSUYA,AWOJOODU, ANTHONY
申请号:
EP12760144
公开号:
EP2685971A4
申请日:
2012.03.16
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
The present application discloses strategies to recruit and mobilize stem cells using S1P receptor selective agonists and antagonists as wells as regulators of chemokine receptors. In an in vivo ischemic model, S1P1/S1P3 activation with FTY720 impeded inflammatory cell infiltration and recruited endothelial progenitor cells (EPCs) with the potential to increase microvascular remodeling. S1P3 expression on marrow-derived cells was essential for this remodeling. Concurrent systemic S1P3 and CXCR4 antagonism mobilized hematopoietic stem cells (HSCs) with the ability to engraft and repopulate blood cells. Pre-treatment of donor HSCs with FTY720 increased homing toward SDF-1 and improved engraftment in marrow. FTY720-coated bone allografts coupled with systemic administration of VPC01091 enhanced bone allograft integration and new bone formation in bone defects. MSCs pre-treated with FTY720 exhibited increased migration toward SDF-1, a CXCR4+ ligand. The results show that S1P is a very powerful role player in pharmacological marrow-derived stem cell mobilization and recruitment.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充